Definitive Contract 75N95023C00002

Award Date 1/4/23
Potential Completion Date 1/3/26
Potential Value $7.1M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fort Worth, TX 76107, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Drug Enforcement Administration (DEA), a civilian agency, to the University of North Texas Health Science Center at Fort Worth (UNTHSC). The award, valued at $116,610.72, is a Blanket Purchase Agreement (BPA) call for in vivo testing of opioids. The period of performance runs from September 30, 2024 to September 29, 2025, with a final completion date of February 3, 2026. UNTHSC is a U.S. state government entity and educational institution that...
The Department of Justice Drug Enforcement Administration awarded a firm fixed price Blanket Purchase Agreement call contract valued at one hundred twenty-five thousand four hundred seventy-six dollars and sixty cents ($125,476.60) to the University of North Texas Health Science Center at Fort Worth for pharmacological testing and evaluation of abuse potential of synthetic opioids using in vivo pharmacological studies. Performance will take place in Fort Worth, Texas, with a period of...
The National Institute on Drug Abuse (NIDA) has awarded a $1,272,385 firm-fixed-price contract to The University of Texas Southwestern Medical Center (UT Southwestern) to provide support services for assessing outcomes of health system suicide risk screening programs. The contract has a period of performance through September 25, 2025. As a subcontractor, the Parkland Center for Clinical Innovation (PCCI) will assist in the data linkage and analysis efforts. This contract does not have a...
This is a $5,833,141.44 cost-reimbursable contract awarded by the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, to Virginia Commonwealth University (VCU) for medication discovery research using rat models of drug relapse. The contract has a period of performance from July 10, 2019 to July 9, 2024, with the initial award covering the first year. This contract was awarded under a competitive solicitation that was open to small businesses only, but no...
The Department of Justice Drug Enforcement Administration issued a call order against its Blanket Purchase Agreement for $91,309 to the University of North Texas Health Science Center at Fort Worth for pharmacological testing services. The purpose of this order is to support the DEA's testing needs through July 2020. As the prime contractor, the University of North Texas Health Science Center will leverage its expertise in pharmacological research to deliver drug analysis that will aid the DEA...
The Department of Justice Drug Enforcement Administration awarded a $149,839.91 firm fixed price call order contract to the University of North Texas Health Science Center at Fort Worth for pharmacological testing services. To be performed under the terms of an existing blanket purchase agreement, the University will provide drug testing and analysis to support the DEA's law enforcement programs through February 2024. No set-aside provisions were applied to this award made through the Fiscal...
This is a $984,086.02 firm fixed-price definitive contract awarded by the National Institutes of Health National Institute of Allergy and Infectious Diseases (NIH NIAID) to the University of North Texas Health Science Center at Fort Worth (UNTHSC). The contract is for "THERAPEUTICS TESTING IN MURINE MODELS OF BACTERIAL THIGH & LUNG INFECTIONS" and does not have a set-aside designation. UNTHSC is an academic medical center that provides medical and scientific services to federal...
This is a firm fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the University of North Texas Health Science Center at Fort Worth (UNTHSC). The contract, valued at $242,031.86, is for "Therapeutics Testing in Murine Models of Bacterial Thigh and Lung Infections." UNTHSC, an academic medical center, will provide services related to the pre-clinical evaluation of...
The federal contract award is for the National Institute on Drug Abuse (NIDA), a civilian agency of the U.S. government, to procure supplies from Med Associates, Inc., a for-profit, woman-owned manufacturer of scientific equipment and software. The $16,287.50 firm fixed price purchase order is to provide the laboratory members of NIDA researcher Leandro Vendruscolo with items needed to perform experiments involving alcohol and opioids in mice and rats. The contract does not have a set-aside...
This is a cost-reimbursement contract awarded by the National Institute on Drug Abuse (NIDA), part of the U.S. Department of Health and Human Services, to Virginia Commonwealth University (VCU) for $11,354,157.46. The contract is for preclinical medication discovery and abuse liability testing services in support of NIDA's mission. The contract has a period of performance from February 22, 2017 to February 21, 2018, with a potential completion date of February 16, 2025. This award is not...

This federal contract award, valued at $7,096,467, was issued by the National Institute on Drug Abuse (NIDA) to the University of North Texas Health Science Center at Fort Worth (UNTHSC). The contract is to use rodent behavioral models to identify potential pharmacotherapies for substance use disorders.

UNTHSC, a U.S. state government entity and educational institution, has extensive experience providing medical, scientific, and forensic services to federal agencies. The center has existing indefinite delivery contracts with NIDA and the Bureau of Prisons, allowing it to deliver ongoing research and healthcare support.

This contract was not set aside for any specific business category. UNTHSC will leverage its expertise in areas like drug discovery and pre-clinical pharmacology to conduct studies involving mouse and rat behavioral testing with drugs like cocaine, methamphetamine, and THC. The results will help NIDA identify new treatment options for substance abuse.

Generated 12/18/24, 9:15 AM